| Groups of Related Enforcement Actions | Country(ies) Where Bribes Were Paid |
|---|---|
| 3M's Involvement in China between 2014 and 2017 | China |
| AGA Medical's Involvement in China in 1997 | China |
| Airbus' Involvement in China between 2008 and 2015 | China |
| Akamai's Involvement in China from 2013 to 2015 | China |
| Albemarle Corp's Involvement in Multiple Countries between 2009 and 2017 | China, India, Indonesia, United Arab Emirates, Vietnam |
| AMAC International's Involvement in China in 2005 | China |
| AstraZeneca's Involvement in China and Russia between 2005 and 2010 | China, Russia |
| Avery Dennison's Involvement in China in 2002 | China, Indonesia, Pakistan |
| Avon's Involvement in China between 2004 to 2008 | China |
| Barclays' Involvement in Asia from 2009 to 2013 | China, South Korea |
| Biomet's Involvement in Argentina, Brazil and China from 2000 to 2008 and in Brazil and Mexico from 2008 to 2013 | Argentina, Brazil, China, Mexico |
| Bristol-Myers Squibb's Involvement in China between 2009 and 2014 | China |
| Bruker's Involvement in China between 2005 to 2011 | China |
| Cardinal Health's Involvement in China between 2010 and 2016 | China |
| Clear Channel Outdoor Holdings and iHeartMedia's Involvement in China between 2012 and 2017 | China |
| Control Components' Involvement in Multiple Countries from 2003 to 2007 | China, Malaysia, South Korea, United Arab Emirates |
| Credit Suisse's Involvement in Asia | China |
| Daimler's Involvement in Multiple Countries between 1998 and 2008 | Bulgaria, China, Croatia, Ghana, Greece, Hungary, Indonesia, Iraq, Latvia, Liberia, Libya, Nigeria, North Korea, Poland, Romania, Russia, Saudi Arabia, Turkmenistan, Uzbekistan, Vietnam, Yemen |
| Deutsche Bank's Involvement in Asia between 2006 and 2015 | China, Russia |
| Deutsche Bank's Involvement in Multiple Countries between 2009 and 2015 | China, Italy, Saudi Arabia, United Arab Emirates |
| Diagnostics Products's Involvement in China from 1991 to 2002 | China |
| Diebold's Involvement in China and Indonesia from 2005 to 2010 | China, Indonesia, Russia |
| Dimon & Standard's Involvement in Asia and Europe from 1996 to 2004 | China, Greece, Indonesia, Kyrgyzstan, Thailand |
| Dun & Bradstreet's Involvement in China between 2006 and 2012 | China |
| Eli Lilly Subsidiaries' Involvement in Multiple Countries between 1994 and 2009 | Brazil, China, Poland, Russia |
| Ericsson's Involvement in Multiple Countries between 2000 and 2017 | China, Djibouti, Indonesia, Kuwait, Saudi Arabia, Vietnam |
| Faro Technologies' Involvement in China in 2003 | China |
| Former Morgan Stanley Executive's Involvement in China from 2004 to 2007 | China |
| Fresenius Medical Care's Involvement in Multiple Countries between 2009 and 2016 | Angola, Benin, Bosnia and Herzegovina, Burkina Faso, Cameroon, China, Gabon, Ivory Coast, Mexico, Morocco, Niger, Saudi Arabia, Senegal, Serbia and Montenegro, Spain, Turkey |
| FTX Trading's Involvement in China between 2019 and 2022 | China |
For each country represented on the navigation bar, this heat map identifies the number of groups of related Enforcement Actions filed since the statute's enactment that allege improper payments to that country. The navigation bar organizes the data by count and color, putting the country with the most groups of related Enforcement Actions at the top in red, and the country with the fewest groups of related Enforcement Actions on the bottom in yellow. A country will be counted only once per group of related of Enforcement Actions regardless of the number of bribes allegedly offered or paid to officials in that country. If a single group of related Enforcement Actions implicates more than one country, that group will be counted once for each unique country implicated. The data used to generate this graphic were culled from publicly available documents filed in connection with the Enforcement Actions, and may not reflect all countries where bribes were offered or paid. See About Us - Datasets for the definition of " Enforcement Action."